Breast Cancer Clinical Trial

Digital Breast Tomosynthesis Guided Tomographic Optical Breast Imaging (TOBI)

Summary

Screening for breast cancer improves early detection of aggressive cancers and has been shown to reduce breast cancer related mortality. Currently, mammography is the most effective way of detecting early stage, non palpable breast cancers. However, mammography only reveals the breast structure, and cannot say much about the breast physiological state. We propose Tomographic Optical Breast Imaging (TOBI) as an inexpensive, patient friendly technique that is non-invasive and does not use non-ionizing radiation. TOBI uses near infrared light and by measuring how such light passes through the breast, images of blood volume and hemoglobin oxygenation can be obtained. In this study, TOBI is combined with digital breast tomosynthesis (DBT, a form of 3D mammography) and our hypothesis is that the TOBI-DBT combined images can be used to diagnose breast cancer with significantly improved sensitivity and specificity compared to DBT alone.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Any adult female volunteers of any race or ethnic background, between the ages of 30 to 80, either

scheduled for a clinically indicated diagnostic mammogram or percutaneous biopsy.
presenting for breast cancer treatment

Exclusion Criteria:

Under 30 years old or over 80 years old
Is pregnant or thinks she may become pregnant.
Open wounds on breast
Breast implants
Any condition that impairs the ability to give informed consent

Study is for people with:

Breast Cancer

Estimated Enrollment:

375

Study ID:

NCT02033486

Recruitment Status:

Unknown status

Sponsor:

Massachusetts General Hospital

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Stefan Carp
Charlestown Massachusetts, 02129, United States More Info
Stefan Carp, PhD
Contact
617-643-2230
[email protected]
Mansi Saksena, MBBS
Contact
617-726-3093
[email protected]
Mansi Saksena, MBBS
Principal Investigator
Stefan Carp, PhD
Sub-Investigator

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

375

Study ID:

NCT02033486

Recruitment Status:

Unknown status

Sponsor:


Massachusetts General Hospital

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider